Dr. Danielle Schlosser is a Senior Clinical Scientist at Verily Life Sciences, an Alphabet company. Dr. Schlosser acts as the Behavioral Health Clinical Lead, overseeing the tech-enabled behavioral health portfolio. Prior to joining Verily, she was an Assistant Professor of Psychiatry at the University of California, San Francisco Weill Institute for Neurosciences and the Director of an NIMH-funded translational neuroscience lab. Dr. Schlosser’s lab developed digital therapeutics for individuals with serious mental illness. Her work was featured in several media outlets including, CNN, Technical Times, Fortune Magazine, and the Pacific Standard. Dr. Schlosser serves as Board Chair of OneFifteen, as well as a member of the Mental Health America Board of Directors, USC Schaeffer Center as a Scientific Advisor, and remains a faculty mentor for several fellowship programs at UCSF, including the distinguished ACGME Clinical Informatics Fellowship Program; the Clifford Attkinson Clinical Services Research Training Program; and the Psychology and Medicine: An Integrative Research Approach fellowship.